576 related articles for article (PubMed ID: 8381885)
41. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease].
Shimazu C; Fukuda T; Yugeta N; Yasuda K; Wakasugi K; Tahara C; Miyajima Y; Kazama M
Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841
[TBL] [Abstract][Full Text] [Related]
43. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
44. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
45. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
46. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
Iijima K
Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
[No Abstract] [Full Text] [Related]
47. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
49. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
50. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
[TBL] [Abstract][Full Text] [Related]
51. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
53. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
54. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
55. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
56. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
[TBL] [Abstract][Full Text] [Related]
57. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
58. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
Matsuno K; Araki K
Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
[TBL] [Abstract][Full Text] [Related]
59. Disseminated intravascular coagulation (DIC).
Mammen EF
Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
Yamada S; Asakura H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
